Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism
- 13 December 2006
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 33 (2), 286-292
- https://doi.org/10.1007/s00134-006-0482-1
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Biomarkers in Acute Cardiac DiseaseJournal of the American College of Cardiology, 2006
- Usefulness of Bedside Testing for Brain Natriuretic Peptide to Identify Right Ventricular Dysfunction and Outcome in Normotensive Patients With Acute Pulmonary EmbolismThe American Journal of Cardiology, 2006
- N-Terminal Pro–Brain Natriuretic Peptide or Troponin Testing Followed by Echocardiography for Risk Stratification of Acute Pulmonary EmbolismCirculation, 2005
- Biomarker-based risk assessment model in acute pulmonary embolismEuropean Heart Journal, 2005
- Diagnosis of Right Ventricular Dysfunction in Acute Pulmonary Embolism Using Helical Computed TomographyThe American Journal of Cardiology, 2005
- Acute Pulmonary Embolism: Part ICirculation, 2003
- Prognostic Role of Brain Natriuretic Peptide in Acute Pulmonary EmbolismCirculation, 2003
- Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary EmbolismCirculation, 2003
- Low Pro-Brain Natriuretic Peptide Levels Predict Benign Clinical Outcome in Acute Pulmonary EmbolismCirculation, 2003
- Aortic atresia. Diagnostic cardiac catheterization in first week of life.Heart, 1971